Your browser doesn't support javascript.
loading
Glibenclamide and HMR1098 normalize Cantú syndrome-associated gain-of-function currents.
Houtman, Marien J C; Chen, Xingyu; Qile, Muge; Duran, Karen; van Haaften, Gijs; Stary-Weinzinger, Anna; van der Heyden, Marcel A G.
  • Houtman MJC; Division of Heart and Lungs, Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Chen X; Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.
  • Qile M; Division of Heart and Lungs, Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Duran K; Center for Molecular Medicine, Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Haaften G; Center for Molecular Medicine, Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Stary-Weinzinger A; Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.
  • van der Heyden MAG; Division of Heart and Lungs, Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands.
J Cell Mol Med ; 23(8): 4962-4969, 2019 08.
Article en En | MEDLINE | ID: mdl-31119887

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteocondrodisplasias / Sulfonamidas / Canales de Potasio / Gliburida / Cardiomegalia / Glucurónidos / Bloqueadores de los Canales de Potasio / Hipertricosis Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteocondrodisplasias / Sulfonamidas / Canales de Potasio / Gliburida / Cardiomegalia / Glucurónidos / Bloqueadores de los Canales de Potasio / Hipertricosis Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article